Biotech Values

[mcbio]

Esperion acquired other drugs that were in the old esperion pipeline.

the drug that was very difficult to make was apo milano and I believe that pfizer licensed that to the medicines company.

Esperion's Web site makes specific reference to ETC-1002 and notes it has completed five clinical trials. See: http://www.esperion.com/therapies/clinical-trials.php . Are you sure this is not the same drug that PFE had been working on? I do see a PR from the company makes reference to this drug being orally-available and I don't believe that was the case with the prior drug that PFE was involved with.